CYMODIC
Live / Applied — Fifth extension granted (statement of use) (as of 11 Sept 2026)
What this means for you
Not registered yet, but its 23 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97853487
- Mark type
- Stylized text
- Filed
- 23 Mar 2023
- Published for opposition
- 16 Jan 2024
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 11 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2026 — SOU EXTENSION 5 GRANTED
- 22 Jul 2026 — SOU EXTENSION 5 FILED
- 25 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 12 May 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 12 May 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 May 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 May 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2026 — SOU EXTENSION 4 GRANTED
- 02 Feb 2026 — SOU EXTENSION 4 FILED
- 02 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED